A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts

View/ open
Author
Gomez-Cabrero, David
Walter, S.
Abugessaisa, I.
Miñambres-Herraiz, R.
Palomares, L.B.
Butcher, Lee
Erusalimsky, Jorge
Garcia-Garcia, F.J.
Carnicero, J.
Hardman, T.C.
Mischak, H.
Zürbig, P.
Hackl, M.
Grillari, J.
Fiorillo, E.
Cucca, F.
Cesari, M.
Carrie, I.
Colpo, M.
Bandinelli, S.
Feart, C.
Peres, K.
Dartigues, J-F
Helmer, C.
Viña, J.
Olaso, G.
García-Palmero, I.
Martínez, J. G.
Jansen-Dürr, P.
Grune, T.
Weber, D.
Lippi, G.
Bonaguri, C.
Sinclair, A. J.
Tegner, J.
Rodriguez-Mañas, L.
on behalf of the FRAILOMIC initiative
Date
2021-02-18Acceptance date
2021-02-02
Type
Article
acceptedVersion
Publisher
Springer
ISSN
2509-2715
2509-2723 (electronic)
Metadata
Show full item recordAbstract
Phenotype-specific omic expression patterns in people with frailty could provide invaluable insight into the underlying multi-systemic pathological processes and targets for intervention. Classical approaches to frailty have not considered the potential for different frailty phenotypes. We characterized associations between frailty (with/without disability) and sets of omic factors (genomic, proteomic, and metabolomic) plus markers measured in routine geriatric care. This study was a prevalent case control using stored biospecimens (urine, whole blood, cells, plasma, and serum) from 1522 individuals (identified as robust (R), pre-frail (P), or frail (F)] from the Toledo Study of Healthy Aging (R=178/P=184/F=109), 3 City Bordeaux (111/269/100), Aging Multidisciplinary Investigation (157/79/54) and InCHIANTI (106/98/77) cohorts. The analysis included over 35,000 omic and routine laboratory variables from robust and frail or pre-frail (with/without disability) individuals using a machine learning framework. We identified three protective biomarkers, vitamin D3 (OR: 0.81 [95% CI: 0.68–0.98]), lutein zeaxanthin (OR: 0.82 [95% CI: 0.70–0.97]), and miRNA125b-5p (OR: 0.73, [95% CI: 0.56–0.97]) and one risk biomarker, cardiac troponin T (OR: 1.25 [95% CI: 1.23–1.27]). Excluding individuals with a disability, one protective biomarker was identified, miR125b-5p (OR: 0.85, [95% CI: 0.81–0.88]). Three risks of frailty biomarkers were detected: pro-BNP (OR: 1.47 [95% CI: 1.27–1.7]), cardiac troponin T (OR: 1.29 [95% CI: 1.21–1.38]), and sRAGE (OR: 1.26 [95% CI: 1.01–1.57]). Three key frailty biomarkers demonstrated a statistical association with frailty (oxidative stress, vitamin D, and cardiovascular system) with relationship patterns differing depending on the presence or absence of a disability.
Journal/conference proceeding
GeroScience;
Citation
Gomez-Cabrero, D., Walter, S., Abugessaisa, I., Miñambres-Herraiz, R., Palomares, L.B., Butcher, L., Erusalimsky, J.D., Garcia-Garcia, F.J., Carnicero, J., Hardman, T.C., Mischak, H. et al (2021) 'A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts', GeroScience, pp.1-13. https://doi.org/10.1007/s11357-021-00334-0
Description
Article published in GeroScience available at https://doi.org/10.1007/s11357-021-00334-0
Sponsorship
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Collections
Related items
Showing items related by title, author, subject and abstract.
-
'In search of ‘Omics'-based biomarkers to predict risk of frailty and its consequences in older individuals: the FRAILOMIC initiative
Erusalimsky, Jorge; Grillari, Johannes; Grune, Tilman; Jansen-Duerr, Pidder; Lippi, Giuseppe; Sinclair, Alan; Tegner, Jesper; Vina, Jose; Durrance-Bagale, Anna; Minambres, Rebecca; Viegas, Marcelo; Rodriguez-Manas, Leocadio (Karger, 2016)An increase in the number of older people experiencing disability and dependence is a critical aspect of the demographic change that will emerge within Europe due to the rise in life expectancy. In this scenario, prevention ... -
Laboratory biomarkers and frailty: presentation of the FRAILOMIC initiative
Lippi, Giuseppe; Jansen-Duerr, Pidder; Viña, Jose; Durrance-Bagale, Anna; Abugessaisa, Imad; Gomez-Cabrero, David; Tegnér, Jesper; Grillari, Johannes; Erusalimsky, Jorge; Sinclair, Alan; Rodriguez-Mañaa, Leocadio (Pub Med, 2015-09)The FRAILOMIC consortium (available at: http://www.frailomic.org/) was created and funded under the European FP7 framework in order to overcome these limitations. The consortium comprises seven small and medium-sized ... -
Higher sRAGE levels predict mortality in frail older adults with cardiovascular disease
Butcher, Lee; Carnicero, Jose Antonio; Peres, Karine; Colpo, Marco; Gomez-Cabrero, David; Dartigues, Jean-François; Bandinelli, Stefania; Garcia-Garcia, Francisco Jose; Manas, Leocadio Rodriguez; Erusalimsky, Jorge (Karger, 2021-01-21)Introduction: The evidence that blood levels of the soluble receptor for advanced glycation end products (sRAGE) predict mortality in people with cardiovascular diseases (CVD) is inconsistent. To clarify this matter, we ...